Letter to the Editor
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 16, 2022; 10(29): 10817-10819
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10817
“Helicobacter pylori treatment guideline: An Indian perspective”: Letter to the editor
Raktim Swarnakar, Shiv Lal Yadav
Raktim Swarnakar, Shiv Lal Yadav, Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, New Delhi-110029, India
Author contributions: Swarnakar R designed and analyzed the letter; Swarnakar R and Yadav SL performed the research and wrote the letter.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Raktim Swarnakar, MBBS, MD, Doctor, Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, New Delhi-110029, India. raktimswarnakar@hotmail.com
Received: July 9, 2022
Peer-review started: July 9, 2022
First decision: August 1, 2022
Revised: August 2, 2022
Accepted: September 1, 2022
Article in press: September 1, 2022
Published online: October 16, 2022
Processing time: 81 Days and 17 Hours
Core Tip

Core Tip: A high prevalence of Helicobacter pylori (H. pylori) has been observed in many areas of India. There are recent guidelines and consensus on the management of H. pylori in India. We would like to correlate our guidelines with other existing guidelines through this letter-to-the-editor article.